SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Deparle Nancy Ann – ‘4’ for 4/21/06 re: Guidant Corp.

On:  Tuesday, 4/25/06, at 9:27pm ET   ·   For:  4/21/06   ·   As:  Director   ·   Accession #:  929987-6-41   ·   File #:  1-13388

Previous ‘4’:  ‘4’ on 4/4/06 for 3/31/06   ·   Next:  ‘4’ on / for 5/3/06   ·   Latest:  ‘4’ on 11/17/23 for 11/15/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/25/06  Deparle Nancy Ann                 4          Director    1:11K  Guidant Corp.                     Guidant Corp.

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML     11K 
                Securities by an Insider --                                      
                deparleform4_ex.xml/2.2


        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
Plain Text rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0202
Document Type:  4
Period of Report:  4/21/06
Not Subject to Section 16:  1
Issuer:
Issuer CIK:  929987
Issuer Name:  GUIDANT CORP
Issuer Trading Symbol:  GDT
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1144511
Owner Name:  DEPARLE NANCY ANN
Reporting Owner Address:
Owner Street 1:  C/O GUIDANT CORPORATION
Owner Street 2:  111 MONUMENT CIRCLE, 29TH FLOOR
Owner City:  INDIANAPOLIS
Owner State:  IN
Owner ZIP Code:  46204-5129
Owner State Description:
Reporting Owner Relationship:
Is Director?  Yes
Is Officer?  No
Is Ten Percent Owner?  No
Is Other?  No
Non-Derivative Table:
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  4/21/06
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  D
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  3,000
Transaction Price Per Share:
Footnote ID:  F1
Transaction Acquired-Disposed Code:
Value:  D
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Table:
Derivative Transaction:
Security Title:
Value:  Director Stock Option (right to buy)
Conversion or Exercise Price:
Value:  37.7
Transaction Date:
Value:  4/21/06
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  D
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  7,500
Transaction Price Per Share:
Footnote ID:  F2
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Footnote ID:  F2
Expiration Date:
Value:  5/18/12
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  7,500
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Transaction:
Security Title:
Value:  Director Stock Option (right to buy)
Conversion or Exercise Price:
Value:  40.925
Transaction Date:
Value:  4/21/06
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  D
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  10,000
Transaction Price Per Share:
Footnote ID:  F2
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Footnote ID:  F2
Expiration Date:
Value:  5/19/13
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  10,000
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Transaction:
Security Title:
Value:  Director Stock Option (right to buy)
Conversion or Exercise Price:
Value:  59.01
Transaction Date:
Value:  4/21/06
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  D
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  10,000
Transaction Price Per Share:
Footnote ID:  F2
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Footnote ID:  F2
Expiration Date:
Value:  5/18/14
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  10,000
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Derivative Transaction:
Security Title:
Value:  Director Stock Option (right to buy)
Conversion or Exercise Price:
Value:  73.31
Transaction Date:
Value:  4/21/06
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  D
Equity Swap Involved?  No
Transaction Amounts:
Transaction Shares:
Value:  7,500
Transaction Price Per Share:
Footnote ID:  F2
Transaction Acquired-Disposed Code:
Value:  D
Exercise Date:
Footnote ID:  F2
Expiration Date:
Value:  5/16/15
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  7,500
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  0
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Footnotes:
Footnote - F1:  Pursuant to an Agreement and Plan of Merger, dated as of January 25, 2006 (the "Merger Agreement"), by and among Boston Scientific Corporation ("Boston Scientific"), Guidant Corporation ("Guidant"), and Galaxy Merger Sub, Inc., each share of Guidant common stock issued and outstanding immediately prior to the effectiveness of the merger on April 21, 2006 (the "Effective Time"), was converted into the right to receive (i) 1.6799 shares of Boston Scientific common stock (the "Exchange Ratio") and (ii) $42.28 in cash (which includes an aggregate per share interest payment of $0.28).
Footnote - F2:  Pursuant to the Merger Agreement, at the Effective Time, this option was assumed by Boston Scientific and converted into an option to purchase that number of shares of Boston Scientific common stock (rounded down to the nearest whole share) equal to the sum of (x) the product of (A) the number of shares of Guidant common stock subject to this option and (B) the Exchange Ratio and (y) the product of (A) the number of shares of Guidant common stock subject to this option and (B) the Cash Portion Option Exchange Multiple, at an exercise price per share of Boston Scientific common stock (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the aggregate exercise price for the shares of Guidant common stock subject to this option by (2) the aggregate number of shares of Boston Scientific common stock to be subject to such option after giving effect to such adjustments. The Cash Portion Option Exchange Multiple was 1.9056.
Owner Signature:
Signature Name:  Diane Barker by Power of Attorney for Nancy-Ann Min DeParle
Signature Date:  4/25/06


↑Top
Filing Submission 0000929987-06-000041   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., Apr. 19, 11:48:35.1pm ET